---
title: 'Feasibility Assessment of a Biomarker-Guided Kidney-Sparing Sepsis Bundle:
  The Limiting Acute Kidney Injury Progression In Sepsis Trial'
date: '2023-08-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37614799/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230824181008&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Although the COVID-19 pandemic impeded recruitment, the
  actual implementation of a therapeutic strategy that deploys a KDIGO-based KSSB
  of care guided by risk stratification using urinary [TIMP2]•[IGFBP7] seems feasible
  and appears to be safe in patients with ...'
disable_comments: true
---
CONCLUSIONS: Although the COVID-19 pandemic impeded recruitment, the actual implementation of a therapeutic strategy that deploys a KDIGO-based KSSB of care guided by risk stratification using urinary [TIMP2]•[IGFBP7] seems feasible and appears to be safe in patients with ...